ISO 27001 Certificate
SOC 1 Type I Certificate
SOC 2 Type II Certificate
PCI DSS
HIPAA
RGPD
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
ISOSOC2 Type 1SOC2 Type 2PCI DSSHIPAAGDPR

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Novo Nordisk A.I CyberSecurity Scoring

Novo Nordisk

Company Details

Linkedin ID:

novo-nordisk

Employees number:

64,615

Number of followers:

2,243,164

NAICS:

3254

Industry Type:

Pharmaceutical Manufacturing

Homepage:

novonordisk.com

IP Addresses:

0

Company ID:

NOV_1789310

Scan Status:

In-progress

AI scoreNovo Nordisk Risk Score (AI oriented)

Between 800 and 849

https://images.rankiteo.com/companyimages/novo-nordisk.jpeg
Novo Nordisk Pharmaceutical Manufacturing
Updated:
  • Powered by our proprietary A.I cyber incident model
  • Insurance preferes TPRM score to calculate premium
globalscoreNovo Nordisk Global Score (TPRM)

XXXX

https://images.rankiteo.com/companyimages/novo-nordisk.jpeg
Novo Nordisk Pharmaceutical Manufacturing
  • Instant access to detailed risk factors
  • Benchmark vs. industry & size peers
  • Vulnerabilities
  • Findings

Novo Nordisk Company CyberSecurity News & History

Past Incidents
0
Attack Types
0
No data available
Ailogo

Novo Nordisk Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

🔒
Incident Predictions locked
Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

🔒
A.I. Risk Score Predictions locked
Access Monitoring Plan
statics

Underwriter Stats for Novo Nordisk

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Novo Nordisk in 2025.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Novo Nordisk in 2025.

Incident Types Novo Nordisk vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novo Nordisk in 2025.

Incident History — Novo Nordisk (X = Date, Y = Severity)

Novo Nordisk cyber incidents detection timeline including parent company and subsidiaries

Novo Nordisk Company Subsidiaries

SubsidiaryImage

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Loading...
similarCompanies

Novo Nordisk Similar Companies

Eli Lilly and Company

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and

Merck Group

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad

Hetero Drugs Ltd

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm

Alembic Pharmaceuticals Limited

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol

PT Kalbe Farma, Tbk

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching t

Teva Pharmaceuticals

At Teva, we're proud to be a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, our commitment to bettering health has never wavered. Every day, we challenge ourselves to p

The Janssen Pharmaceutical Companies of Johnson & Johnson

At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving ac

MENARINI Group

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic

CVS Pharmacy

CVS Pharmacy is America’s leading retail pharmacy with more than 9,600 locations nationwide. For more than 50 years, CVS Pharmacy has offered customers the products and services they need to stay on their path to better health. In addition to our pharmacies, our stores feature on-trend beauty depart

newsone

Novo Nordisk CyberSecurity News

November 11, 2025 08:00 AM
Practical Ways To Reduce 24/7 Cybersecurity Risks For New York Firms: 2026 Guide

Fisch Solutions releases a comprehensive cybersecurity protection guide for Tri-State businesses, featuring 24/7 SOC monitoring and advanced...

November 02, 2025 07:00 AM
CPT of South Florida Is Offers Cyber Security Consulting Services to Manage AI Cybersecurity Risks

This press release was orginally distributed by ReleaseWire. Ft. Lauderdale, FL -- (ReleaseWire) -- 11/02/2025 -- CPT of South Florida is a...

October 17, 2025 07:00 AM
Wilson Sonsini Advises Omeros on Asset Purchase and License Agreement with Novo Nordisk

On October 15, 2025, Novo Nordisk and Omeros Corporation announced that they have entered into a definitive asset purchase and license...

September 08, 2025 07:00 AM
Sectors Up Close: Cybersecurity 'is a never-ending arms race'

Companies and governments are spending an escalating fortune on IT security but cybercrime is only growing worse.

August 20, 2025 07:00 AM
Corporate Wins: Intel, Palo Alto Networks, and Novo Nordisk Drive Market Optimism

In a week marked by a surge of positive corporate news, three industry giants—Intel, Palo Alto Networks, and Novo Nordisk—have delivered...

August 19, 2025 09:15 AM
Why Cybersecurity Vendor Palo Alto’s Stock Is Rallying In Today’s Premarket

Palo Alto Networks' (PANW) stock rose nearly 6% in the early premarket trading on Tuesday, after the cybersecurity firm reported better-than-expected...

August 19, 2025 07:00 AM
Big Demand for Cyber Protection Powers Palo Alto Networks Results, Outlook

Palo Alto Networks beat profit and sales estimates on increased demand for tougher tools to fight hackers. The cybersecurity firm also gave...

August 08, 2025 07:00 AM
Stagflation Nation, My Cybersecurity Trade, More Fed Games

Here's my take on the calls for intensifying stagflation and why we won't see a 1970s repeat, my view of the Fed pick, and why I added to...

July 14, 2025 07:00 AM
Dan Ives Bets On Cybersecurity As 'Biggest Subsector'…

Wedbush Securities analyst Daniel Ives has placed his bets on cybersecurity as the “biggest subsector” in the technology sector in 2025.

faq

Frequently Asked Questions

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.

Novo Nordisk CyberSecurity History Information

Official Website of Novo Nordisk

The official website of Novo Nordisk is https://www.novonordisk.com.

Novo Nordisk’s AI-Generated Cybersecurity Score

According to Rankiteo, Novo Nordisk’s AI-generated cybersecurity score is 833, reflecting their Good security posture.

How many security badges does Novo Nordisk’ have ?

According to Rankiteo, Novo Nordisk currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Does Novo Nordisk have SOC 2 Type 1 certification ?

According to Rankiteo, Novo Nordisk is not certified under SOC 2 Type 1.

Does Novo Nordisk have SOC 2 Type 2 certification ?

According to Rankiteo, Novo Nordisk does not hold a SOC 2 Type 2 certification.

Does Novo Nordisk comply with GDPR ?

According to Rankiteo, Novo Nordisk is not listed as GDPR compliant.

Does Novo Nordisk have PCI DSS certification ?

According to Rankiteo, Novo Nordisk does not currently maintain PCI DSS compliance.

Does Novo Nordisk comply with HIPAA ?

According to Rankiteo, Novo Nordisk is not compliant with HIPAA regulations.

Does Novo Nordisk have ISO 27001 certification ?

According to Rankiteo,Novo Nordisk is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Industry Classification of Novo Nordisk

Novo Nordisk operates primarily in the Pharmaceutical Manufacturing industry.

Number of Employees at Novo Nordisk

Novo Nordisk employs approximately 64,615 people worldwide.

Subsidiaries Owned by Novo Nordisk

Novo Nordisk presently has no subsidiaries across any sectors.

Novo Nordisk’s LinkedIn Followers

Novo Nordisk’s official LinkedIn profile has approximately 2,243,164 followers.

NAICS Classification of Novo Nordisk

Novo Nordisk is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Novo Nordisk’s Presence on Crunchbase

Yes, Novo Nordisk has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/novonordisk.

Novo Nordisk’s Presence on LinkedIn

Yes, Novo Nordisk maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/novo-nordisk.

Cybersecurity Incidents Involving Novo Nordisk

As of December 11, 2025, Rankiteo reports that Novo Nordisk has not experienced any cybersecurity incidents.

Number of Peer and Competitor Companies

Novo Nordisk has an estimated 5,412 peer or competitor companies worldwide.

Novo Nordisk CyberSecurity History Information

How many cyber incidents has Novo Nordisk faced ?

Total Incidents: According to Rankiteo, Novo Nordisk has faced 0 incidents in the past.

What types of cybersecurity incidents have occurred at Novo Nordisk ?

Incident Types: The types of cybersecurity incidents that have occurred include .

Incident Details

What are the most common types of attacks the company has faced ?

Additional Questions

cve

Latest Global CVEs (Not Company-Specific)

Description

FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description

Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.

Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description

The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N

Access Data Using Our API

SubsidiaryImage

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=novo-nordisk' -H 'apikey: YOUR_API_KEY_HERE'

What Do We Measure ?

revertimgrevertimgrevertimgrevertimg
Incident
revertimgrevertimgrevertimgrevertimg
Finding
revertimgrevertimgrevertimgrevertimg
Grade
revertimgrevertimgrevertimgrevertimg
Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network Security

Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)

Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)

Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat Intelligence

Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Top LeftTop RightBottom LeftBottom Right
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
Users Love Us Badge